Metoprolol Succinate
NDC 72516-033, Metoprolol Succinate, tablet, extended release, from Oryza Pharmaceuticals, Inc.
- Product NDC
- 72516-033
- Status
- Listed
- Labeler
- Oryza Pharmaceuticals, Inc
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207206
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72516-033 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METOPROLOL TARTRATE200 mg/1
Pharmacologic classes
Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72516-033-01 | 72516003301 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-033-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6cfe96df-bd75-432d-b2c2-e26143ca36ddNADAC price for package 72516003301
GET /v1/drugs/nadac/72516003301
Use it
Look up 72516-033 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72516-033 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72516-033. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.